BFC Planning’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Buy
10,449
+2,912
+39% +$409K 0.06% 290
2026
Q2
$952K Sell
7,537
-6,335
-46% -$835K 0.04% 412
2026
Q1
$1.93M Sell
13,872
-752
-5% -$105K 0.09% 234
2025
Q4
$1.8M Buy
14,624
+2,510
+21% +$305K 0.08% 245
2025
Q3
$1.34M Buy
12,114
+775
+7% +$88.1K 0.1% 188
2025
Q2
$1.26M Buy
11,339
+964
+9% +$103K 0.1% 185
2025
Q1
$1.16M Sell
10,375
-116
-1% -$12K 0.1% 179
2024
Q4
$969K Buy
10,491
+503
+5% +$45.3K 0.08% 209
2024
Q3
$837K Buy
+9,988
New +$762K 0.07% 231

Other funds holding GILD

BFC Planning's GILD Position: Q3 2026 in Review

BFC Planning increased its Gilead Sciences (GILD) stake by 39% in Q3 2026, buying an estimated $409K and bringing the position to 10,449 shares worth $1.56M. The position accounts for 0.06% of the portfolio, ranked #290.

BFC Planning first reported a position in GILD in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.93M in Q1 2026. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • BFC Planning held 10,449 shares of Gilead Sciences worth $1.56M as of Q3 2026.
  • BFC Planning bought 2,912 Gilead Sciences shares in Q3 2026, an estimated $409K.
  • Gilead Sciences made up 0.06% of BFC Planning's portfolio in Q3 2026, its #290 holding.
  • BFC Planning first reported a position in Gilead Sciences in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Gilead Sciences position peaked at $1.93M in Q1 2026.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.